Caseware UK (AP4) 2022.0.179 2022.0.179 2023-07-312023-07-31222022-08-01falseNo description of principal activitytruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. SC540619 2022-08-01 2023-07-31 SC540619 2021-08-01 2022-07-31 SC540619 2023-07-31 SC540619 2022-07-31 SC540619 c:Director1 2022-08-01 2023-07-31 SC540619 c:Director2 2022-08-01 2023-07-31 SC540619 c:RegisteredOffice 2022-08-01 2023-07-31 SC540619 d:FurnitureFittings 2022-08-01 2023-07-31 SC540619 d:FurnitureFittings 2023-07-31 SC540619 d:FurnitureFittings 2022-07-31 SC540619 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-08-01 2023-07-31 SC540619 d:ComputerEquipment 2022-08-01 2023-07-31 SC540619 d:ComputerEquipment 2023-07-31 SC540619 d:ComputerEquipment 2022-07-31 SC540619 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-08-01 2023-07-31 SC540619 d:OwnedOrFreeholdAssets 2022-08-01 2023-07-31 SC540619 d:CurrentFinancialInstruments 2023-07-31 SC540619 d:CurrentFinancialInstruments 2022-07-31 SC540619 d:CurrentFinancialInstruments d:WithinOneYear 2023-07-31 SC540619 d:CurrentFinancialInstruments d:WithinOneYear 2022-07-31 SC540619 d:ShareCapital 2023-07-31 SC540619 d:ShareCapital 2022-07-31 SC540619 d:RetainedEarningsAccumulatedLosses 2023-07-31 SC540619 d:RetainedEarningsAccumulatedLosses 2022-07-31 SC540619 c:OrdinaryShareClass1 2022-08-01 2023-07-31 SC540619 c:OrdinaryShareClass1 2023-07-31 SC540619 c:OrdinaryShareClass1 2022-07-31 SC540619 c:FRS102 2022-08-01 2023-07-31 SC540619 c:AuditExempt-NoAccountantsReport 2022-08-01 2023-07-31 SC540619 c:FullAccounts 2022-08-01 2023-07-31 SC540619 c:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: SC540619










IRVINE DALLAS MEDICAL LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

 
IRVINE DALLAS MEDICAL LIMITED
 

COMPANY INFORMATION


Directors
Dr N Irvine 
Dr Y McWilliams 




Registered number
SC540619



Registered office
Unit 14 City Quay
Camperdown Street

Dundee

DD1 3JA




Accountants
EQ Accountants Limited
Chartered Accountants

14 City Quay

Dundee

DD1 3JA





 
IRVINE DALLAS MEDICAL LIMITED
REGISTERED NUMBER: SC540619

STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2023

As restated
2023
2022
£
£

Fixed assets
  

Tangible assets
 4 
625
441

  
625
441

Current assets
  

Debtors: amounts falling due within one year
 5 
444
-

Cash at bank and in hand
  
889
821

  
1,333
821

Creditors: amounts falling due within one year
 6 
(8,711)
(9,202)

Net current liabilities
  
 
 
(7,378)
 
 
(8,381)

Total assets less current liabilities
  
(6,753)
(7,940)

Provisions for liabilities
  

Deferred tax
  
(119)
(84)

  
 
 
(119)
 
 
(84)

Net liabilities
  
(6,872)
(8,024)


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
(6,972)
(8,124)

  
(6,872)
(8,024)


Page 1

 
IRVINE DALLAS MEDICAL LIMITED
REGISTERED NUMBER: SC540619

STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 JULY 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 April 2024.




Dr N Irvine
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
IRVINE DALLAS MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

1.


General information

Irvine Dallas Medical Limited is a private company, limited by shares, domiciled in Scotland with registration number SC540619. The registered office is Unit 14 City Quay, Camperdown Street, Dundee, United Kingdom, DD1 3JA. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

As at 31 July 2023 the Balance Sheet reports a net liability position. The company can only continue to operate with the support of the directors, who have confirmed that they will continue to financially support the company for the forseeable future. Therefore, the company will continue to adopt the going concern basis for the preparation of the financial statements.

 
2.3

Turnover

Turnover  is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Turnover  is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Turnover  from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
IRVINE DALLAS MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

2.Accounting policies (continued)

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
33%
straight line
Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 4

 
IRVINE DALLAS MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

2.Accounting policies (continued)

 
2.6

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Statement of financial position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2023
        2022
            No.
            No.







Employees
2
2


4.


Tangible fixed assets





Fixtures and fittings
Computer equipment
Total

£
£
£



Cost or valuation


At 1 August 2022
-
3,679
3,679


Additions
728
220
948



At 31 July 2023

728
3,899
4,627



Depreciation


At 1 August 2022
-
3,238
3,238


Charge for the year on owned assets
241
523
764



At 31 July 2023

241
3,761
4,002



Net book value



At 31 July 2023
487
138
625



At 31 July 2022
-
441
441

Page 5

 
IRVINE DALLAS MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023

5.


Debtors

2023
2022
£
£


Other debtors
444
-

444
-



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Other taxation and social security
235
206

Other creditors
8,062
8,600

Accruals and deferred income
414
396

8,711
9,202



7.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



100 (2022 - 100) Ordinary shares of £1 each
100
100



Page 6